Abstract
Get full access to this article
View all access options for this article.
References
1.
Funderburg
NT
,
Jiang
Y
,
Debanne
SM
,
Storer
N
,
Labbato
D
,
Clagett
B
,
Robinson
J
,
Lederman
MM
, and
McComsey
GA
: Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy . Clin Infect Dis , 2014 ; 58 :588 –595 .
2.
Hearps
AC
,
Martin
GE
,
Rajasuriar
R
, and
Crowe
SM
: Inflammatory co-morbidities in HIV+ individuals: Learning lessons from healthy ageing . Curr HIV/AIDS Rep , 2014 ; 11 :20 –34 .
3.
Palmer
CS
and
Crowe
SM
: The role of glucose and lipid metabolism in the pathogenesis of HIV-1 infection . Curr Trends Immunol , 2012 ; 13 :37 –50 .
4.
Freemerman
AJ
,
Johnson
AR
,
Sacks
GN
,
Milner
JJ
,
Kirk
EL
,
Troester
MA
,
Macintyre
AN
,
Goraksha-Hicks
P
,
Rathmell
JC
, and
Makowski
L
: Metabolic reprogramming of macrophages: Glucose transporter (GLUT1)-mediated glucose metabolism drives a pro-inflammatory phenotype . J Biol Chem , 2014 ; 289 :7884 –7896 .